Evidence map›Paper›PMID 36671998›Full record

ArticleBrain sciences2022

A Special Case of Relapsing-Remitting Bilateral Encephalitis: Without Epilepsy, but Responding to Rituximab and with a Brain Biopsy Coinciding with Rasmussen Encephalitis.

Pei Liu, Xuemei Lin, Shenghua Zong, Yan Yan, Zhongzhong Liu, Qingli Lu, Qiaoqiao Chang, Songdi Wu

Open access · goldAbstract readCase Reports
In one paragraph

Article in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Pei LiuDepartment of Neurology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.
Xuemei LinDepartment of Neurology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.
Shenghua ZongDepartment of Psychiatry and Neuropsychology, Division Translational Neuroscience, School for Mental Health and Neuroscience, Maastricht University, 6229 HX Maastricht, The Netherlands.
Yan YanDepartment of Pathology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.
Zhongzhong LiuDepartment of Neurology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.
Qingli LuDepartment of Neurology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.
Qiaoqiao ChangDepartment of Neurology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.
Songdi WuDepartment of Neurology, The First Hospital of Xi'an (The First Affiliated Hospital of Northwest University), Xi'an 710002, China.ORCID 0000-0003-1186-3322
Northwest University · CNMaastricht University · NL

Funding

Science and Technology Program of Shaanxi Province 2021SF-333Scientific Research Project of Shaanxi Health Commission 2022C005
6 · The paper itself

Abstract

A nine-year-old boy manifested with headache, progressive mild cognitive decline and hemiparesis, but without clinical epileptic seizures (with abnormal EEG waves). Brain magnetic resonance imaging (MRI) showed bilateral cortical lesions mainly on the right hemisphere, and new lesions developed in frontal, parietal, occipital and temporal lobes around the old lesions presenting as a lace-like or ring-like enhancement in T1 with contrast over a disease course of five years. A suspected diagnosis of primary angiitis of the central nervous system was initially considered. Treated with high-dose corticosteroids, intravenous immunoglobulins and monthly pulse cyclophosphamide, his symptoms worsened with the intracranial lesion progression. Brain biopsy of the right frontal lobe was performed nearly five years after onset; prominent neuronal loss, a microglial nodule, as well as parenchymal and perivascular lymphocytic infiltrate within the cortex were found, which coincided with RE pathology changes. Encouragingly, after a regimen of rituximab, lesions on the follow-up brain MRI tended to be stable. Apparently, it was immune-mediated, but did not strictly fit any known disease entity, although it was similar to RE. We summarize this unique case, including clinical characteristics, imaging and pathology findings. We also discuss the diagnosis and treatment, focusing on comparison to RE as well as other possible neurological diseases.

Indexed as

brain biopsyencephalomalaciaRasmussen encephalitisrelapsing–remitting bilateral encephalitisrituximab

Identifiers

PMID36671998
PMCPMC9856488
OpenAlexW4312073629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.